Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
SUL-238 in Parkinson Disease: NCT07322887 Clinical Landscape Report 2026
16 October 2026
NCT07322887 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Irpagratinib in Hepatocellular Carcinoma: NCT07327034 Clinical Landscape Report 2026
16 October 2026
NCT07327034 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Hepatocellular Carcinoma: NCT07327788 Clinical Landscape Report 2026
16 October 2026
NCT07327788 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Oxaliplatin in Locally Advanced Pancreatic Adenocarcinoma: NCT07325214 Clinical Landscape Report 2026
16 October 2026
NCT07325214 clinical landscape for Locally Advanced Pancreatic Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Sintilimab in Hepatocellular Carcinoma: NCT07324824 Clinical Landscape Report 2026
16 October 2026
NCT07324824 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Icaritin in Hepatocellular Carcinoma: NCT07328828 Clinical Landscape Report 2026
16 October 2026
NCT07328828 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HSK-39004 in Pulmonary Disease, Chronic Obstructive: NCT07331402 Clinical Landscape Report 2026
16 October 2026
NCT07331402 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
QX-008N in Pulmonary Disease, Chronic Obstructive: NCT07330310 Clinical Landscape Report 2026
16 October 2026
NCT07330310 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Yttrium [90Y] chloride in Hepatocellular Carcinoma: NCT07334483 Clinical Landscape Report 2026
16 October 2026
NCT07334483 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Erdosteine in Pulmonary Disease, Chronic Obstructive: NCT07329946 Clinical Landscape Report 2026
16 October 2026
NCT07329946 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
HSK-47388 in Colitis, Ulcerative: NCT07335055 Clinical Landscape Report 2026
16 October 2026
NCT07335055 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bevacizumab biosimilar (Innovent Biologics) in Hepatocellular Carcinoma: NCT07328802 Clinical Landscape Report 2026
16 October 2026
NCT07328802 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.